Sign in
Enrolling by invitationNo phase

0.01% and 0.025% Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change

Key facts

Who runs it
China Medical University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
420 people, planned
Started
11 Apr 2026
Expected to end
31 Mar 2027
Type of study
Interventional, 6 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Auricular acupoint stimulation
  • 0.01% concentration atropine drops
  • 0.025% atropine eye drops
  • Artificial Tears (AT)
Record updated
4 June 2026

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Children aged 6-12 years
  • Myopia after cycloplegia (spherical equivalent > -0.5 D)
  • Astigmatism and anisometropia < -2.0 D
  • Intraocular pressure < 21 mmHg

Who cannot take part

  • Previous or current use of contact lenses or orthokeratology lenses
  • Previous or current use of bifocal or progressive lenses
  • Infection
  • Eyelid disorders
  • Ear disorders
  • Hematologic or other systemic diseases
  • History of atropine allergy
  • Ulceration
  • Amblyopia or strabismus
  • Use of other pharmacological or invasive treatments for myopia during the study period (spectacles allowed)
  • Non-compliance with study protocol for more than 7 days

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 6 and 12 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized, double-blind, placebo-controlled pilot trial evaluates the efficacy and safety of low-dose atropine (0.01%, 0.025%) combined with auricular acupoint stimulation for myopia control in children. While 0.05% atropine is effective, it may pose corneal toxicity risks, highlighting the need for safer alternatives. Auricular acupuncture has shown potential benefits in systematic reviews.

Read full original descriptionShow less

A total of 420 children aged 6-12 will be randomized into six groups receiving different treatments or placebo, with a 12-week follow-up. The auricular Eye Point will be stimulated, and comprehensive visual and ocular assessments will be conducted, including corneal endothelial monitoring.

This study aims to determine the synergistic effect of combined therapy and provide a safer treatment option, laying the foundation for future large-scale trials.

The 6 groups in the trial

  • Acupoint plus 0.01% AtropineTreatment being tested

    Auricular acupoint stimulation + 0.01% atropine (0.5 mL unit dose, preservative-free)

    Treatment: Auricular acupoint stimulation and 0.01% concentration atropine drops

  • 0.01% AtropinePlacebo, for comparison

    0.01% atropine (0.5 mL unit dose, preservative-free)

    Treatment: 0.01% concentration atropine drops

  • Acupoint plus 0.025% AtropineTreatment being tested

    Auricular acupoint stimulation + 0.025% atropine (0.5 mL unit dose, preservative-free)

    Treatment: Auricular acupoint stimulation and 0.025% atropine eye drops

  • 0.025% AtropinePlacebo, for comparison

    0.025% atropine (0.5 mL unit dose, preservative-free)

    Treatment: 0.025% atropine eye drops

  • Acupoint plus Artificial tearsTreatment being tested

    Auricular acupoint stimulation + artificial tears (0.5 mL unit dose, preservative-free)

    Treatment: Auricular acupoint stimulation and Artificial Tears (AT)

  • Artificial tearsPlacebo, for comparison

    Artificial tears (0.5 mL unit dose, preservative-free)

    Treatment: Artificial Tears (AT)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pilot Randomized, Partially Double Blind, Placebo-Controlled Trial of 0.01% and 0.025%Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change
Criteria questions
Built from NCT07537166, who can take part
Record updated
4 June 2026